Interleukin 10 Attenuates Neointimal Proliferation and Inflammation in Aortic Allografts by a Heme Oxygenase-Dependent Pathway
Interleukin 10 (IL-10) is a pleiotropic cytokine with well known antiinflammatory, immunosuppressive, and immunostimulatory properties. Chronic allograft rejection, characterized by vascular neointimal proliferation, is a major cause of organ transplant loss, particularly in heart and kidney transpl...
Saved in:
Published in: | Proceedings of the National Academy of Sciences - PNAS Vol. 102; no. 20; pp. 7251 - 7256 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
National Academy of Sciences
17-05-2005
National Acad Sciences |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Interleukin 10 (IL-10) is a pleiotropic cytokine with well known antiinflammatory, immunosuppressive, and immunostimulatory properties. Chronic allograft rejection, characterized by vascular neointimal proliferation, is a major cause of organ transplant loss, particularly in heart and kidney transplant recipients. In a Dark Agouti to Lewis rat model of aortic transplantation, we evaluated the effects of a single intramuscular injection of a recombinant adeno-associated viral vector (serotype 1) encoding IL-10 (rAAV1-IL-10) on neointimal proliferation and inflammation. rAAV1-IL-10 treatment resulted in a significant reduction of neointimal proliferation and graft infiltration with macrophages and T and B lymphocytes. The mechanism underlying the protective effects of IL-10 in aortic allografts involved heme oxygenase 1 (HO-1) because inhibition of HO activity reversed not only neointimal proliferation but also inflammatory cell infiltration. Our results indicate that IL-10 attenuates neointimal proliferation and inflammatory infiltration and strongly imply that HO-1 is an important intermediary through which IL-10 regulates the inflammatory responses associated with chronic vascular rejection. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 Contributed by Kenneth I. Berns, March 31, 2005 Abbreviations: H&E, hematoxylin/eosin; HO-1, heme oxygenase 1; rAAV, recombinant adeno-associated virus; SMC, smooth muscle cells; SnPP, tin protoporphyrin; DA, Dark Agouti. Author contributions: K.I.B., C.C.T., and A.A. designed research; S.C., M.H.K., and O.Y.G. performed research; C.W., M.C.-T., J.S.D., R.J., P.E.C., W.W.H., K.M.M., B.P.C., K.I.B., M.A.A., and T.R.F. contributed new reagents/analytic tools; S.C., M.H.K., C.W., and A.A. analyzed data; and S.C., M.H.K., and A.A. wrote the paper. S.C. and M.H.K. contributed equally to this work. To whom correspondence should be addressed at: University of Alabama at Birmingham, Division of Nephrology, ZRB 614, 1530 3rd Avenue South, Birmingham, AL 35294. E-mail: agarwal@uab.edu. |
ISSN: | 0027-8424 1091-6490 |
DOI: | 10.1073/pnas.0502407102 |